Metraipolis › archive › dc_18efffd9fa84

2C-D — Wikipedia (en)

Source: Wikipedia (en)
Original: https://en.wikipedia.org/wiki/2C-D
License (as archived): CC-BY-SA-4.0
Archived: 2026-11-06T12:12:56.594Z
SHA-256 of the archived text: f1a13ae162039caac9fd2dae7697ba97d7ef4188a015945e214382cf4925d0b6
Stable URL of this page: https://metraipolis.com/documento/dc_18efffd9fa84

How to cite

2C-D — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/2C-D (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_18efffd9fa84 (Metraipolis archive dc_18efffd9fa84, sha256 f1a13ae162039caac9fd2dae7697ba97d7ef4188a015945e214382cf4925d0b6)

BibTeX

@misc{dc18efffd9fa84,
  title = {2C-D — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/2C-D},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_18efffd9fa84; sha256 f1a13ae162039caac9fd2dae7697ba97d7ef4188a015945e214382cf4925d0b6},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/2C-D. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

2C-D, also known as 4-methyl-2,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and 2C families. It has an unusually wide and gradual dose range and at low doses produces claimed cognitive enhancer-like effects, mild stimulant effects, and mild perceptual effects, whereas at high doses, it produces robust psychedelic effects. The drug is taken orally. It acts as an agonist of the serotonin 5-HT2 receptors, including of the serotonin 5-HT2A receptor. The drug is structurally related to other psychedelic and related phenethylamines such as its higher homologues DOM and Ariadne (4C-D) and other 2C psychedelics like 2C-B and 2C-E. 2C-D was first described in the literature by Beng T. Ho and colleagues in 1970. Its properties and effects in humans were described by Alexander Shulgin and colleagues in 1975. The drug was extensively studied by Hanscarl Leuner under the names DMM-PEA and LE-25 in psychedelic-assisted psychotherapy in Germany in the 1970s and 1980s. It was also informally studied by Darrell Lemaire as a potential "smart drug" in the 1970s and 1980s. 2C-D was first encountered as a novel designer drug by 2005. It became a controlled substance in the United States in 2012.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «2C-D» — https://en.wikipedia.org/wiki/2C-D
Wikidata Q209260: «composto chimico» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q209260
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/2C-D?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1382939206, consultata il 2026-11-06T12:10:18.010Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: b9fb1fb6720b97c729307dd5ecb8a2edd09fa791e073c4a8c3daf97f4f1c7a59